Beijing Huafeng Lianbo Technology Co., Ltd
Beijing Huafeng Lianbo, established in 2005, develops active pharmaceutical ingredients, focusing on compounds like Paclitaxel and Doxorubicin.
Introduction
Beijing Huafeng Lianbo Technology Co., Ltd., founded in 2005, is a technology-driven company dedicated to the production of active pharmaceutical ingredients and intermediates. With a robust focus on innovation, the company excels in new product development and conducts specialized research on compounds such as Paclitaxel, Doxorubicin Hydrochloride, Docetaxel, Epirubicin, and Doxorubicin.
Information
Categories
More Websites
The company specializes in manufacturing intermediates and heterocyclic building blocks, focusing on new pharmaceuticals, advanced intermediates, custom synthesis, and technology services.